Publication | Closed Access

Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy

Nr4a2 Confers ChemoresistancePostoperative ChemotherapySurgical OncologyGastrointestinal OncologyMedicinePathologyColorectal CancerUnfavorable PrognosisCancer GeneticsOncologyRadiation OncologyCancer ResearchTumor Biology